---
layout: archive
title: "Work in Progress"
permalink: /workinprogress/
author_profile: true

---

## Physician practice styles and technology

- **A Hard Look at ‘Soft’ Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany.** with Daniel Avdic, [CINCH working paper series 2021(08). doi: 10.17185/duepublico/74978.](https://duepublico2.uni-due.dereceive/duepublico_mods_00074978)  
  [An earlier version was nomiated as 10% best submissions to Health Care Management Division of the Academy of Management 2021.](https://journals.aom.org/doi/10.5465/AMBPP.2021.226).


- **The effect of biosimilar prescription targets for erythropoiesis-stimulating agents on physicians’ prescribing behaviour in Germany.** with Benjamin Birkner

  Under review. [Data Availability and Provenance Statements.](https://osf.io/dn9uy/?view_only=f346d8dcc80e4dc1b18b22094c0c8278).


## Health and innovation

- [**Stakeholder Participation in Regulatory Decision-Making**, with Victoria Lauenroth and Tom Stargardt](https://journals.aom.org/doi/10.5465/AMBPP.2018.11748abstract), please email for the working paper.

- **Tradeoffs in access to new drug therapies between the US and Germany**, with Amitabh Chandra and Huseyin Naci

- **Seeking system certification, innovation, or both? – Examining the relationships towards high quality care in specialized cancer care**, with Tim Brand and Eva Goetjes



- - -


## Economics & management of pharmaceutical markets

- [**Do medicine shortages reduce access to care and increase pharmaceutical expenditure? A retrospective analysis of Switzerland 2015‒2020.** with Stefan Felder](https://wwz.unibas.ch/de/wwz-forum/projekte-und-publikationen/fv-78/)

   Under review. [Data Preparation and Analysis Codes.](https://osf.io/z57vg/?view_only=b8548abd78e743c0982c66289923966f)


- **Mind the gap! Explaining changes in multisource drug utilization over time - a decomposition approach.** with Sotiris Vandoros. Please email for a working paper.

- **Access to novel treatment pathways of oral antidiabetics by health insurance system in Germany** with Eva Goetjes

- - -



